+143.3%
MRNA vs GRMN
+14.3%
+129.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GRMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.3% | -2.1% | -3.3% |
| 7D | -10.1% | -1.4% | -8.7% | -10.0% |
| 30D | +126.7% | -13.1% | +139.8% | +130.1% |
| 3M | +184.1% | +14.9% | +169.2% | +168.2% |
| 6M | +143.3% | +13.1% | +130.2% | +131.4% |
| All | +143.3% | +14.3% | +129.0% | +131.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GRMN.
Daily Out/Under-Performance
Portfolio return minus GRMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GRMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling